Immuneering Corp (IMRX)
1.695
-0.14
(-7.38%)
USD |
NASDAQ |
Nov 13, 16:00
1.70
0.00 (0.00%)
After-Hours: 20:00
Immuneering Revenue (Annual)
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
December 31, 2022 | 0.317M |
December 31, 2021 | 2.08M |
Date | Value |
---|---|
December 31, 2020 | 2.312M |
December 31, 2019 | 1.920M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
0.317M
Minimum
2022
2.312M
Maximum
2020
1.657M
Average
2.000M
Median
Revenue (Annual) Benchmarks
Singular Genomics Systems Inc | 2.911M |
Biomarin Pharmaceutical Inc | 2.419B |
Integra Lifesciences Holdings Corp | 1.542B |
Eton Pharmaceuticals Inc | 31.64M |
Tenon Medical Inc | 2.928M |